Symbol="GKOS"
AssetType="Common Stock"
Name="Glaukos Corp"
Description="Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California."
CIK="1192448"
Exchange="NYSE"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="229 AVENIDA FABRICANTE, SAN CLEMENTE, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3563587000"
EBITDA="-81652000"
PERatio="None"
PEGRatio="1.64"
BookValue="10.1"
DividendPerShare="0"
DividendYield="0"
EPS="-2.97"
RevenuePerShareTTM="6.2"
ProfitMargin="-0.426"
OperatingMarginTTM="-0.386"
ReturnOnAssetsTTM="-0.0719"
ReturnOnEquityTTM="-0.241"
RevenueTTM="296794000"
GrossProfitTTM="213883000"
DilutedEPSTTM="-2.97"
QuarterlyEarningsGrowthYOY="18.96"
QuarterlyRevenueGrowthYOY="0.106"
AnalystTargetPrice="84.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="7.12"
PriceToBookRatio="3.845"
EVToRevenue="7.48"
EVToEBITDA="-52.92"
Beta="1.289"
num_52WeekHigh="80.28"
num_52WeekLow="40.45"
num_50DayMovingAverage="71.12"
num_200DayMovingAverage="54.8"
SharesOutstanding="48208700"
DividendDate="None"
ExDividendDate="None"
symbol="GKOS"
open="73.68"
high="75.32"
low="72.55"
price="75.03"
volume="583951.00"
latest_trading_day="2023-08-15"
previous_close="73.81"
change="1.22"
change_percent="1.6529%"
aroon_positive_momentum_days="81"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="81"
Volume_recent_avg="458224"
Change_recent_avg="0.13"
Delta_recent_avg="1.93"
Variance_recent_avg="0.97"
Change_ratio_recent_avg="0.18"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="81"
Aroon_momentum_negative="19"
image_negative_thumbnail_id_1="1122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_negative_thumbnail_id_2="1098"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_neutral_thumbnail_id_1="594"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="613"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_positive_thumbnail_id_2="616"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0092.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
